A new study has revealed that taking statins reduces the risk of developing the chronic inflammatory disease, rheumatoid arthritis.
The researchers studied 1.8-million members of Maccabi Healthcare Services (a health maintenance organization [HMO]) in Israel to identify adults who regularly took statins and did not have rheumatoid arthritis.
Orthotics
Orthotics is concerned using artificial supports or braces. Orthoses play an integral role in the rehabilitation of a large number of lives.
Advertisement
After adjusting for factors that could bias the analysis, they found that patients who persistently took statins had a lower risk (risk ratio of 0.58) of developing rheumatoid arthritis compared with patients who did not.
However, there was only a small short-term decrease in risk ratio in patients taking statins and the development of osteoarthritis.
The authors conclude, "Larger, systematic, controlled, prospective studies with high efficacy statins, particularly in younger adults who are at increased risk of rheumatoid arthritis, are needed to confirm these findings and to clarify the exact nature of the biological relationship between adherence to statin therapy and the incidence of rheumatoid arthritis."
The findings are published in this week's PLoS Medicine.
Source: ANI
The authors conclude, "Larger, systematic, controlled, prospective studies with high efficacy statins, particularly in younger adults who are at increased risk of rheumatoid arthritis, are needed to confirm these findings and to clarify the exact nature of the biological relationship between adherence to statin therapy and the incidence of rheumatoid arthritis."
The findings are published in this week's PLoS Medicine.
Source: ANI
Statins Could Prevent Cataract
Statins could cut the chances of developing cataracts by nearly 40 per cent, Israeli researchers say.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The CDSCO has approved the intravenous administration of AstraZeneca Pharma India's liver cancer drug, Tremelimumab Concentrate.
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.